First sexual intercourse and high parity are the most influential factors of precancerous cervical lesion
Downloads
Objectives: to analyze the relationship between characteristics, parity and maternal reproductive history with the risk of cervical pre-cancerous lesions.
Materials and Methods: Cross Sectional Survey, in 2016 Non-Communicable Disease study, with a population of women aged 25-64 years, living in urban areas. A total of 1,547 samples were selected from the census blocks that were prepared to IVA examination. The variables in this article are maternal characteristics, menarche, age of first sexual intercourse, number of partners, parity and contraceptive use, as independent variables and cervical pre-cancerous lesions as dependent variables.
Results: Factors influencing cervical pre-cancerous lesions were: Menarche with a value of P = 0.018; Age of first sexual intercourse with a value of P = 0,000; Number of sexual partners with a value of P = 0.023; and parity with a value of P = 0.049. Multivariate test results show that the age of first time having sex less than 20 years has a 2.3 risk; Mothers with high parity (> 4 children) and having more than one sexual partner have a 16.5 risk.
Conclusion: Menarche, age of first sexual intercourse, number of sexual partners and parity affect the incidence of cervical cancerous lesions. The most influential Factors are: the age of first sexual intercourse less than 20 years, and mothers with high parity who have more than one sexual partner.Rasjidi I. Epidemiologi Kanker Serviks. Indonesis J Cancer. 2009;3(3):103-8
Ministry of Health, Republic of Indonesia. Buku saku pencegahan kanker leher rahim & kanker payudara. Jakarta: Direktorat Pengendalian Penyakit Tidak Menular. 2009. p. 1.
WHO. Global incidence and prevalence of selected curable sexually tranmitted infection. WHO Library Cataloguing in Publication data. 2012. p. 1–2.
World Health Organization. Comprehensive Cervical Cancer Control - A Guide to Essential Practice. 2nd edition. Geneva: WHO Press. 2014.
World Health Organization. Cervical Cancer. 2017; Available from: http://www.who.int/ mediacentre/news/releases/2014/preventing-cervical-cancer/en/
Ministry of Health, Republic of Indonesia. Skrining Kanker Leher Rahim dengan Metode Inspeksi Visual Asam Asetat (IVA). 2008. p. 1–41.
Saleem A, Bekele A, Fitzpatrick MB, et al. Knowledge and awareness of cervical cancer in Southwestern Ethiopia is lacking. PLoS One [Internet]. 2019;14(11):1–12. Available from: http://dx.doi.org/10.1371/journal.pone.0215117
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Komite Penanggulangan Kanker Nasional. Kanker Serviks [Internet]. 2015. Available from: http://kanker.kemkes.go.id/guidelines/PPKServiks.pdf
Balitbangkes. Riset Kesehatan Dasar 2013. Jakarta; 2013.
Ministry of Health, Republic of Indonesia. Laporan riset penyakit tidak menular: tumor payudara dan lesi prakanker serviks. Jakarta; 2016.
Wiyono S, Iskandar M, Suprijono. Inspeksi Visual Asam Asetat (IVA) untuk deteksi dini lesi prakanker serviks. Media Med Indones. 2012;43(3):116–21.
McGraw SL, Rutgers. Update on prevention and screening of cervical cancer. World J Clin Oncol. 2014;5(4):744–52.
Widyanti D, Destariyani E, Heryati K, Andriani L. Implementation Of Health Bpjs Service System In Cervical Cancer Screening In Bengkulu City. In: 1st International Conference on Inter-Professional Health Collaboration (ICIHC). 2019. p. 308–11.
Nindrea RD. Prevalensi dan faktor yang mempengaruhi lesi pra kanker serviks pada wanita. J Endur. 2017;2(February):53–61.
Naz MSG, Kariman N, Ebadi A, et al. Educational interventions for cervical cancer screening behavior of women: A systematic review. Asian Pacific J Cancer Prev. 2018;19(4):875–84.
Nindrea RD. Prevalensi dan faktor yang mem-pengaruhi lesi pra kanker serviks pada wanita. J Endur. 2017;2(1):56–61.
Momenimovahed Z, Salehiniya H. Incidence, Mortality and risk factors of cervical cancer in the world. Biomed Res Ther. 2017;4(12):1795.
Ministry of Health, Republic of Indonesia. Buku panduan program nasional gerakan pencegahan dan deteksi dini kanker leher rahim dan kanker payudara. 2015. p. 1–47.
Kaunitz, M A. Hereditary Breast Cancer : Does early menarche increase risk ? [Internet]. Massachusetts Medical Society. 2003 [cited 2020 Mar 10]. p. 5–6. Available from: https://search/ proquest.com/docview/1284304720?accountid=169732
Britt K. Menarche, menopause, and breast cancer risk. Lancet Oncol [Internet]. 2012;13(11):1071–2. Available from: http://dx.doi.org/10.1016/S1470-2045(12)70456-4
Yang H, Dai H, Li L, et al. Age at menarche and epithelial ovarian cancer risk: A meta-analysis and Mendelian randomization study. Cancer Med. 2019;8(8):4012–22.
Shields TS, Falk RT, Herrero R, et al. A case-control study of endogenous hormones and cervical cancer. Br J Cancer. 2004;90(1):146–52.
Yuniar I. Faktor-Faktor yang mempengaruhi kejadian kanker serviks di Puskesmas Karang-anyar. J Ilm Kesehat Keperawatan. 2009;5(2):109–18.
Paramita S, Soewarto S, Widodo MAA, Sumitro SB. High parity and hormonal contraception use as risk factors for cervical cancer in East Kalimantan. Med J Indones. 2010. p. 268.
Kusuma LF, Yarso KY. Hormonal contraceptive use as risk factor for breast cancer in young Javanese women. J Med sciene. 2016;48(4):2016.
Leslie HH, Karasek DA, Harris LF, et al. Cervical cancer precursors and hormonal contraceptive use in HIV-positive women. PLoS One. 2014;9(6):1–12.
Awaliyah N, Pradjatmo H, Kusnanto H. Peng-gunaan kontrasepsi hormonal dan kejadian kanker payudara di rumah sakit Dr. Sardjito. J Community Med Public Heal. 2017;33(10):487–94.
Hamel R. Hubungan pemakaian kontrasepsi hormonal dan non hormonal dengan kejadian kanker serviks di Rumah Sakit Prof Dr RD Kandau Manado. J Keperwatan. 2013;1(1).
Green J. Cervical cancer and hormonal contra-ceptives: collaborative reanalysis of individual data for 16 573 women with cervical cancer and 35 509 women without cervical cancer from 24 epidemiological studies. Lancet. 2007;370(9599): 1609–21.
Arbyn M, Castellsagué X, de sanjosé S, et al. Worldwide burden of cervical cancer in 2008. J of Oncol Oncol. 2011;22(12):2675–86.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.
